Both in Pharmaceuticals
Cellectar Biosciences INC NEW vs Vyome Holdings
Over the past year CLRB returned −62.5% and HIND returned −68.9%; their daily moves had a correlation of 0.22.
CLRB −62.5% HIND −68.9%Growth of $1, one year, split-adjusted
| Metric | CLRB | HIND |
|---|---|---|
| Price | $1.24 | $1.72 |
| Market cap | $11.7M | $12.1M |
| Today | +2.48% | +1.18% |
| 1 month | −31.9% | −14.9% |
| 6 months | −51.6% | −15.7% |
| Year to date | −58.0% | −50.0% |
| 1 year | −65.5% | −68.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 43.2% |
| Net margin | — | −2543.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 93.1× |
| Net cash | $34.0M | $7.9M |
| Dividend yield | — | — |
| Volatility (60d) | 66.3% | 40.8% |
| Short % of float | 2.9% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).